PKRP与PKEP治疗高危良性前列腺增生患者临床对照  

Clinical comparison between plasma kinetic resection and plasma kinetic enucleation of the prostate for the treatment of BPH patients with high-risk factors

作　　者：许小林[1] 沈建国[1] 金纪忠[1] 王悦[1] 

机构地区：[1]上海交通大学附属第六人民医院南院泌尿外科,上海201400

出　　处：《国际泌尿系统杂志》2015年第6期832-836,共5页International Journal of Urology and Nephrology

摘　　要：目的 探讨经尿道前列腺等离子切除术（PKRP）与经尿道前列腺等离子剜除术（PKEP）治疗高危前列腺增生症（BPH）患者的疗效及临床优势.方法 本院2011年7月至2014年7月100例高危前列腺增生患者,按照入院先后顺序随机采用PKRP与PKEP各50例.两组手术前后疗效分别比较,并对照分析两组间手术时间、术中出血量、前列腺切除量、术后留置导尿时间、术后住院时间和术后并发症.结果 两组间一般资料比较无统计学差异（P＞0.05）;两组术后IPSS、QOL、Qmax、RUV均明显改善,差异有统计学意义（P＜0.05）;对比而言,PKEP组手术时间短于PKRP组（61.6±15.1 vs 92.2±21.2min）,PKEP组术中出血量少于PKRP组（70.1±51.3 vs 120.8 ±70.7mL）,差异有统计学意义（P＜0.05）,PKEP组术后并发症少于PKRP组,差异有统计学意义（P＜0.05）.但对于＜50g重量的前列腺,两手术组间手术时间无统计学差异（P＞0.05）,对于＞ 100g前列腺,两手术组间术后并发症无统计学差异（P＞0.05）.结论 PKRP与PKEP在治疗高危良性前列腺增生症患者疗效显著,相对而言,PKEP手术时间缩短、术中出血减少、术后并发症减少,对高危患者有明显优势。Objectives To evaluate the clinical efficacy and advantage of plasma kinetic resection of the prostate （PKRP） and plasma kinetic enucleation of the prostate （PKEP） for the treatment of benign prostatic hyperplasia （BPH） patients with high risk factors.Methods 100 patients from July 2011 to July 2014 were randomly divided into the groups of PKRP （n =50） and PKEP （n =50） according to hospital admission sequence.Efficacy of the two groups was evaluated respectively 3 months after surgery.Comparisons were made between the two groups in operative time,blood loss volume,resected prostate tissue weight,duration of indwelling catheter,length of hospital stay after surgery and complications.Results All the base parameters between the two groups have no statistically significant difference （P 〉 0.05）.The preoperative and postoperative indexes have statistically significant difference by paired T -test （P 〈0.05）.Operative time （61.6 ± 15.1 vs 92.2 ±21.2min）,blood loss volume （70.1 ±51.3 vs 120.8 ± 70.7mL） and complications in PKEP group are less than PKRP group with significant differences （P 〈 0.05）.The operative time has no difference in the two groups as for 〈50 weight prostate （P 〉0.05）.The complications data has no difference in the two groups as for 〉 100g weight prostate （P 〉 0.05）.Conclusions PKRP and PKEP are safe and effective for the treatment of BPH patients.Relatively,PKEP is superior to PKRP for BPH patients with high risk factors in consideration of less operative time,less blood loss and less complications.

关 键 词：前列腺增生 经尿道前列腺切除术 

分 类 号：R697.3[医药卫生—泌尿科学]